Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure (Q28575465)

31 January 2017

title

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure (English)

1 reference

31 January 2017

0 references

11

Kenneth Dickstein

0 references

Pål Aukrust

series ordinal

15

object named as

Pål Aukrust

0 references

Thor Ueland

series ordinal

3

object named as

Thor Ueland

1 reference

31 January 2017

14

Lars Gullestad

1 reference

31 January 2017

7

Terje Espevik

1 reference

31 January 2017

1

Arne Yndestad

1 reference

31 January 2017

8

Stig S. Frøland

1 reference

31 January 2017

12

John Kjekshus

1 reference

31 January 2017

10

Geir Christensen

1 reference

31 January 2017

2

Linn Landrø

1 reference

31 January 2017

6

Leif Erik Vinge

1 reference

31 January 2017

9

Cathrine Husberg

1 reference

31 January 2017

13

Erik Øie

1 reference

31 January 2017

4

Christen P. Dahl

1 reference

31 January 2017

Trude H. Flo

5

1 reference

31 January 2017

publication date

1 May 2009

1 reference

31 January 2017

published in

European Heart Journal

1 reference

31 January 2017

volume

30

1 reference

31 January 2017

issue

10

1 reference

31 January 2017

page(s)

1229–1236

1 reference

Role of inflammation in the progression of heart failure

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Dual action of neutrophil gelatinase-associated lipocalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Soluble CD40 ligand in acute and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Plasma myeloperoxidase levels in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

The role of innate immune responses in the heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP088

Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction

21 January 2018

1 reference